EVE Health Group (ASX:EVE) EBITDA Margin %: -133.81% (As of Dec. 2025)


What is EVE Health Group EBITDA Margin %?

EVE Health Group ASX:EVE +2.50% EBITDA Margin % is -133.81% as of Dec. 2025. The stock has 5 warning signs investors should review. Among 1,953 Consumer Packaged Goods companies, EVE Health Group ranks worse than 97.44% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. EVE Health Group's EBITDA for the six months ended in Dec. 2025 was A$-0.85 Mil. EVE Health Group's Revenue for the six months ended in Dec. 2025 was A$0.63 Mil. Therefore, EVE Health Group's EBITDA margin for the quarter that ended in Dec. 2025 was -133.81%.

EVE Health Group  (ASX:EVE) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

EVE Health Group EBITDA Margin % Related Terms

EVE Health Group EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for EVE Health Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EVE Health Group EBITDA Margin % Chart

EVE Health Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -116.32 -211.33 -93.65 -70.62 -82.19

EVE Health Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -72.45 -68.54 -64.81 -106.32 -133.81

ASX:EVE vs KHC, GIS: EBITDA Margin % Comparison

For the Packaged Foods subindustry, EVE Health Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EVE Health Group EBITDA Margin % vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, EVE Health Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where EVE Health Group's EBITDA Margin % falls into.


EVE Health Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

EVE Health Group's EBITDA Margin % for the fiscal year that ended in Jun. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-1.426/1.735
=-82.19 %

EVE Health Group's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-0.847/0.633
=-133.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -133.81% mean?
EVE Health Group (ASX:EVE) has a EBITDA Margin % of -133.81% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on EVE Health Group and its competitors. According to the industry distribution chart, EVE Health Group ranks #1903 out of 1953 companies in the Consumer Packaged Goods industry, placing it in the top 97.4%.
Is EVE Health Group's EBITDA Margin % too high?
EVE Health Group's current EBITDA Margin % is -133.81%. Based on the distribution chart, EVE Health Group ranks #1903 out of 1953 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does EVE Health Group's EBITDA Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, EVE Health Group ranks #1903 out of 1953 companies for EBITDA Margin %. This places EVE Health Group in the lower half of its industry. The industry median EBITDA Margin % is 8.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.99, based on 1,953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on EVE Health Group and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EVE Health Group's current EBITDA Margin % is -133.81%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVE Health Group stock overvalued right now?
Based on GuruFocus' analysis, EVE Health Group (ASX:EVE) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.02 — trading 105% above its estimated fair value. The current EBITDA Margin % is -133.81%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For EVE Health Group (ASX:EVE), the current EBITDA Margin % is -133.81% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EVE Health Group Business Description

Address 245 Churchill Avenue, Suite 1, Subiaco, WA, AUS, 6008
EVE Health Group Ltd is an integrated Health, Nutrition, and Wellness investment company. The company operates in two reporting segments, namely Meluka (branded wellness consumer products) and Nextract.